Cyanotech (OTCMKTS:CYAN) Share Price Crosses Above 200 Day Moving Average – Should You Sell?

Cyanotech Co. (OTCMKTS:CYAN – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.43 and traded as high as $0.5298. Cyanotech shares last traded at $0.5298, with a volume of 811 shares traded.

Cyanotech Price Performance

The stock’s 50-day moving average is $0.48 and its 200 day moving average is $0.43. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 0.42. The company has a market cap of $3.92 million, a PE ratio of -2.12 and a beta of 0.10.

Get Cyanotech alerts:

Cyanotech (OTCMKTS:CYAN – Get Free Report) last issued its quarterly earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter. Cyanotech had a negative return on equity of 16.24% and a negative net margin of 4.82%.

About Cyanotech

(Get Free Report)

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.

Recommended Stories

• Five stocks we like better than Cyanotech
• Datadog’s Drop Says More About Expectations Than Earnings
• D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
• Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
• Solventum Nears Inflection Point As It Begins to Unlock Value

Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.